Thanh Dat Ta

Thanh Dat Ta

Auto-generated profile, based on publicly available information

Thanh Dat Ta

Center for Gene and Protein Research Hanoi Medical University Hanoi Vietnam

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2022 in Anemia
Verified
Journal Article
Open access
PDF file
TNThi Thao Ngo
Thi Thao Ngo
HTHuy-Thinh Tran
Huy-Thinh Tran
TTThanh Dat Ta
Thanh Dat Ta
LPLê Thị Phương
Lê Thị Phương
Phuoc-Dung NguyenPhuoc-Dung Nguyen
Phuoc-Dung Nguyen
TKTran Van Khanh
Tran Van Khanh
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder and is caused by G6PD gene mutations. To date, more than 400 variants in the G6PD gene have been discovered, and about 160 identified variants are associated with a significant decrease in the G6PD enzyme activity. However, the molecular characterization and epidemiological study of G6PD deficiency are still limited in Vietnam. Therefore, we conducted this study to determine the G6PD variants among the Vietnamese populations and evaluate their correlation to G6PD enzyme activity. A total of 339 patients (302 males and 37 females) were enrolled in this study. The G6PD variants were identified by Sanger sequencing. Our results indicate that males are more severely deficient in G6PD than females. This enzyme activity in males (1.27 ± 1.06 IU/g·Hb) is significantly lower than in females (2.98 ± 1.57 IU/g·Hb) ( ). The enzyme activity of the heterozygous-homozygous females and heterozygous females-hemizygous males was found to be significantly different ( ), which is interpreted due to random X-inactivation. For G6PD molecular characteristics, Viangchan (c.871G>A), Canton (c.1376G>T) and Kaiping (c.1388G>A) variants were the most dominant, accounting for 24.48%, 17.70%, and 22.42%, respectively, whereas the highest frequency of complex variants was observed in Viangchan/Silent with 20.35%. In terms of G6PD activity, the Union variant presented the lowest mean value (1.03 IU/g·Hb) compared to the other variants ( ). Computational analysis using Polyphen-2 tool investigated that all variants were relative to G6PD deficiency and separated the levels as benign and damaged. The result will establish effective methods to screen G6PD variants in Vietnam.

7 August 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
HPHung Manh Pham
Hung Manh Pham
DDDuy Phuong Dang
Duy Phuong Dang
TTThanh Dat Ta
Thanh Dat Ta
TLThi Phuong Le
Thi Phuong Le
DPDinh Phong Phan
Dinh Phong Phan
TKTran Van Khanh
Tran Van Khanh
Background: Brugada syndrome (BrS) is a rare genetic disease that causes sudden cardiac death (SCD) and arrhythmia. SCN5A pathogenic variants (about 30% of diagnosed patients) are responsible for BrS.Aims: Lack of knowledge regarding molecular characteristics and the correlation between genotype and phenotype interfere with the risk stratification and finding the optimal treatment in Vietnam. Therefore, we identified SCN5A variants and evaluated the genotype–phenotype correlation of BrS on 117 Vietnamese probands.Materials and Methods: The clinical characteristics and blood samples of BrS patients were collected. To determine SCN5A variants, Sanger sequencing was conducted, and subsequently, these variants were analyzed by bioinformatic tools.Results: In this cohort, the overall rate of detected variants in SCN5A was 25.6%, which could include both pathogenic and benign variants. In genetic testing, 21 SCN5A variants were identified, including eight novels and 15 published variants. Multiple bioinformatic tools were used to predict variant effect with c.551A>G, c.1890+14G>A, c.3338C>T, c.3578G>A, and c.5484C>T as benign, while other variants were predicted as disease‐causing. The family history of SCD (risk ratio [RR] = 4.324, 95% CI: 2.290–8.269, p < 0.001), syncope (RR = 3.147, 95% CI: 1.668–5.982, p = 0.0004), and ventricular tachycardia/ventricular fibrillation (RR = 3.406, 95% CI: 1.722–5.400, p = 0.0035) presented a significantly higher risk in the SCN5A (+) group, consisting of individuals carrying any variant in the SCN5A gene, compared to SCN5A (−) individuals.Conclusion: The results contribute to clarifying the impact of SCN5A variants on these phenotypes. Further follow‐up studies need to be carried out to understand the functional effects of these SCN5A variants on the severity of BrS.

27 March 2023 in Clinical Case Reports
Verified
Journal Article
Open access
NTNam‐Chung Tran
Nam‐Chung Tran
TNTuan Anh Nguyen
Tuan Anh Nguyen
TTThanh Dat Ta
Thanh Dat Ta
TTThinh Huy Tran
Thinh Huy Tran
PNPhuoc‐Dung Nguyen
Phuoc‐Dung Nguyen
TKTran Van Khanh
Tran Van Khanh
Limb‐girdle muscular dystrophy‐type 2C (LGMD2C) is caused by mutations in the SGCG gene. Here, we report a case of a 26‐year‐old male who had inactive walking due to proximal muscle weakness. Targeted next‐generation sequencing found a novel variant c.412C > T (Q138*) in the SGCG gene.